Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-6961
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis ; volume:13 ; number:1 ; day:16 ; month:11 ; year:2021 ; pages:57-73 ; date:1.2022
Diabetes therapy ; 13, Heft 1 (16.11.2021), 57-73, 1.2022
- Creator
-
Gourdy, Pierre
Bonadonna, Riccardo C.
Freemantle, Nick
Mauricio, Didac
Müller-Wieland, Dirk
Bigot, Gregory
Mauquoi, Celine
Ciocca, Alice
Bonnemaire, Mireille
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13300-021-01179-8
- URN
-
urn:nbn:de:101:1-2022050219025417849432
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gourdy, Pierre
- Bonadonna, Riccardo C.
- Freemantle, Nick
- Mauricio, Didac
- Müller-Wieland, Dirk
- Bigot, Gregory
- Mauquoi, Celine
- Ciocca, Alice
- Bonnemaire, Mireille
- SpringerLink (Online service)
Other Objects (12)
Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis
Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis
Impact of age on the effectiveness and safety of insulin glargine 300 U/mL: results from the REALI European Pooled Data Analysis
Glycaemic control with insulin glargine 300 u/ml in individuals with type 2 diabetes and chronic kidney disease: a REALI european pooled data analysis
iGlarLixi (insulin glargine 100 U/mL plus lixisenatide) is effective and well‐tolerated in people with uncontrolled type 2 diabetes regardless of age: a REALI pooled analysis of prospective real‐world data
Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis
Glycaemic control in people with type 2 diabetes mellitus switching from basal insulin to insulin glargine 300 u/ml (gla-300): results from the reali pooled database
Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes : protocol of REALI project
Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis
Effectiveness and safety of iGlarLixi (Insulin Glargine 100 U/mL plus Lixisenatide) in type 2 diabetes according to the timing of daily administration: data from the REALI pooled analysis
Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis
Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis
Impact of age on the effectiveness and safety of insulin glargine 300 U/mL: results from the REALI European Pooled Data Analysis
Glycaemic control with insulin glargine 300 u/ml in individuals with type 2 diabetes and chronic kidney disease: a REALI european pooled data analysis
iGlarLixi (insulin glargine 100 U/mL plus lixisenatide) is effective and well‐tolerated in people with uncontrolled type 2 diabetes regardless of age: a REALI pooled analysis of prospective real‐world data
Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis
Glycaemic control in people with type 2 diabetes mellitus switching from basal insulin to insulin glargine 300 u/ml (gla-300): results from the reali pooled database
Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes : protocol of REALI project
Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis
Effectiveness and safety of iGlarLixi (Insulin Glargine 100 U/mL plus Lixisenatide) in type 2 diabetes according to the timing of daily administration: data from the REALI pooled analysis
Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis
Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis
Impact of age on the effectiveness and safety of insulin glargine 300 U/mL: results from the REALI European Pooled Data Analysis
Glycaemic control with insulin glargine 300 u/ml in individuals with type 2 diabetes and chronic kidney disease: a REALI european pooled data analysis
iGlarLixi (insulin glargine 100 U/mL plus lixisenatide) is effective and well‐tolerated in people with uncontrolled type 2 diabetes regardless of age: a REALI pooled analysis of prospective real‐world data
Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis
Glycaemic control in people with type 2 diabetes mellitus switching from basal insulin to insulin glargine 300 u/ml (gla-300): results from the reali pooled database
Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes : protocol of REALI project
Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis